发明授权
US6004811A Redirection of cellular immunity by protein tyrosine kinase chimeras
失效
蛋白酪氨酸激酶嵌合体细胞免疫的重定向
- 专利标题: Redirection of cellular immunity by protein tyrosine kinase chimeras
- 专利标题(中): 蛋白酪氨酸激酶嵌合体细胞免疫的重定向
-
申请号: US394912申请日: 1995-02-24
-
公开(公告)号: US6004811A公开(公告)日: 1999-12-21
- 发明人: Brian Seed , Charles Romeo , Waldemar Kolanus
- 申请人: Brian Seed , Charles Romeo , Waldemar Kolanus
- 申请人地址: MA Boston
- 专利权人: The Massachussetts General Hospital
- 当前专利权人: The Massachussetts General Hospital
- 当前专利权人地址: MA Boston
- 主分类号: A61K35/14
- IPC分类号: A61K35/14 ; A61K38/00 ; C07K14/705 ; C07K14/725 ; C07K14/73 ; C07K14/735 ; C07K19/00 ; C12N9/12 ; C12P21/04 ; C12N5/00 ; C07H21/00 ; C12N15/09
摘要:
Disclosed is a method of directing a cellular response in a mammal by expressing in a cell of the mammal a chimeric receptor which causes the cells to specifically recognize and destroy an infective agent, a cell infected with an infective agent, a tumor or cancerous cell, or an autoimmune-generated cell. The chimeric receptor includes an extracellular portion which is capable of specifically recognizing and binding the target cell or target infective agent, and (b) an intracellular portion of a protein-tyrosine kinase which is capable of signalling the therapeutic cell to destroy a receptor-bound target cell or a receptor-bound target infective agent. Also disclosed are calls which express the chimeric receptors and DNA encoding the chimeric receptors.
公开/授权文献
- US4982548A Beam hanger for precast foundations 公开/授权日:1991-01-08
信息查询
IPC分类: